Qingwei Jiang

Title: Qingwei Jiang: Innovator in Controlled Release Technology

Introduction

Qingwei Jiang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of controlled release systems. With a total of 2 patents, his work focuses on innovative drug delivery methods that enhance therapeutic efficacy.

Latest Patents

One of his latest patents is the "Osmotic pump controlled release tablet and preparation method thereof." This invention discloses an osmotic pump controlled release tablet composed of a tablet core, a semipermeable membrane, and an optional film coating. The semipermeable membrane is made from a specific ratio of ethyl cellulose and povidone, which is crucial for its functionality. The tablet core includes a drug-containing layer and a push layer, designed to optimize the release of the active ingredient. Another significant patent is for "Thermosensitive liposomes containing therapeutic agents." This invention details a thermosensitive liposome that effectively delivers active agents, comprising various phospholipids with a gel to liquid phase transition temperature between 39°C and 45°C.

Career Highlights

Qingwei Jiang has worked with several reputable organizations, including Celsion Corporation and Beijing Team Hospital Management Co., Ltd. His experience in these companies has allowed him to apply his innovative ideas in practical settings, contributing to advancements in drug delivery systems.

Collaborations

He has collaborated with notable colleagues such as Xingguo Mei and Weiping Yu, further enhancing his research and development efforts in the pharmaceutical field.

Conclusion

Qingwei Jiang's contributions to controlled release technology exemplify the importance of innovation in the pharmaceutical industry. His patents reflect a commitment to improving drug delivery methods, ultimately benefiting patient care and treatment outcomes.